Oncology
Methapharm is actively pursuing strategic alliances and co-development opportunities for its oncology product development pipeline. We are interested in evaluating opportunities from companies or academic institutions with promising intellectual property that are ready for Phase I, II, or III clinical studies. Methapharm is an ideal partner for such opportunities as we can leverage our licensing, regulatory, marketing, and distribution expertise in order to bring promising products to market.
